Drug Approval | May 20, 2026
Bayer’s stroke drug wins fast-track review in US
The development comes as stroke remains one of the world’s biggest health threats
The development comes as stroke remains one of the world’s biggest health threats
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
The Ibuprofen business posted a negative EBITDA of Rs. 179 million in Q4 despite revenue rising 61% year-on-year to Rs. 849 million
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
We are building an AI-native operating system for pharma sales and distribution
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Subscribe To Our Newsletter & Stay Updated
